Beni CEO steps down due to personal health issues
Sarah Pinner, one of the co-founders of Santa Barbara-based Beni, stepped down from her post as CEO of the company on April 12, citing personal health issues as the reason. In a LinkedIn post, Pinner noted that she was “simply no longer mentally or physically healthy enough to continue in this role.” “I can live Read More →
FDA gives nod to Affinity Biosensors’ flagship product
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
South Coast Business & Technology Awards announced 2024 honorees
When Andrew Firestone and Jess Parker founded Santa Barbara-based StonePark Capital together, the two were just happy to create something in the city they’ve known their whole lives. “For us, to be able to build our business in our backyards is very special,” Firestone told the Business Times. Now, almost a decade later, the two Read More →
Briq adds another $8 million in extension round
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
A2 Bio’s new CEO aims to grow platform
James Robinson, the new CEO of Agoura Hills-based A2 Biotherapeutics, has several priorities he wants to tackle, not the least of which is to accelerate the company’s proprietary Tmod cell therapy platform. “First principle for us is to maximize the value of the platform that we’ve built,” Robinson, 54, told the Business Times on April Read More →
Atara reports higher net loss in fourth quarter
Thousand Oaks-based Atara Biotherapeutics reported financial results for the fourth quarter and full year 2023 along with recent business highlights and key upcoming milestones for 2024 on March 28. Atara reported a net loss of $60.5 million or 56 cents per share in the fourth quarter of 2023 along with a net loss of $276.1 million Read More →
Acelyrin reports higher net loss in 2023 as company prepares for breakthrough
Conejo Valley-based Acelyrin, a clinical, pre-revenue biotechnology company, reported its financial results for the full year 2023 on March 28. According to the March 28 report, the company’s net loss for the full year ended Dec. 31 was $381.6 million, compared to $64.8 million for 2022. The company primarily saw expenses increase in research and Read More →
